Why the study?
Long-term data comparing PCI with second-generation drug-eluting stents versus CABG in patients with complex CAD were limited.
Does PCI with second-generation drug-eluting stents reduce all-cause mortality, MI, stroke, and MACE compared to CABG in patients with left main or multivessel CAD?
Does PCI with second-generation drug-eluting stents reduce all-cause mortality, MI, stroke, and MACE compared to CABG in patients with left main or multivessel CAD?
In patients with complex CAD, PCI with second-generation drug-eluting stents is associated with an increased risk of long-term mortality, MI, and MACE compared with CABG.
Answers are grounded in this paper and cite their sources.
Supports CABG over PCI with second-generation DES for survival in left main/multivessel CAD; confirms higher long-term mortality risk.
Long-term data are limited comparing percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (S-DES) vs coronary artery bypass grafting (CABG) in patients with complex coronary artery disease (CAD). We aimed to conduct a systematic review and meta-analysis comparing these interventions in patients with left main or multivessel CAD. We systematically reviewed PubMed, Embase, and Cochrane for studies that compared PCI with S-DES and CABG in patients with left main or multivessel CAD with a minimum mean follow-up period of 3 years. Outcomes of interest were all-cause mortality, myocardial infarction (MI), stroke, and major adverse cardiovascular events (MACE). We extracted data from observational studies as multivariable-adjusted or propensity score-matched hazard ratio to minimize confounding and pooled hazard ratios with 95% confidence intervals (CIs) using a random effects model in Review Manager 5.4.1. We included 10 studies, 3 of which were randomized controlled trials, comprising a total of 26964 patients, of whom 14928 underwent PCI. As compared with CABG, S-DES had a significantly higher risk of all-cause mortality (hazard ratio 1.35; 95% CI 1.22-1.49; P < 0.001; I2 = 0%), MACE (hazard ratio 1.27; 95% CI 1.08-1.50; P = 0.005; I2 = 67%), and MI (hazard ratio 2.43; 95% CI 1.80-3.28; P < 0.01; I2 = 0%). There was no significant difference between groups in incidence of stroke. In this meta-analysis of patients with complex CAD, PCI with S-DES was associated with an increased risk of mortality, MI, and MACE compared with CABG.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: